Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TYO/4512 stock hub

TYO/4512 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TYO/4512is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

12.4B

Tokyo Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TYO/4512

In the news

Latest news · TYO/4512

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.7P50 15.8P75 21.7

Trailing P/En/a

P25 11.7P50 15.2P75 22.3

ROE-1.8

P25 -1.6P50 7.1P75 11.9

ROIC-4.2

P25 -0.6P50 6.2P75 14.3

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TYO/4512 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

211

Groups with data

Currency

JPY

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Japan
Country code	JP
Employees	403
Employees Change	-24%
Employees Change Percent	-5.62
Exchange	Tokyo Stock Exchange
Financial currency	JPY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	JP3991200001
Last refreshed	2026-05-10
Market cap	JPY 12.4B
Price	JPY 357
Price currency	JPY
Rev Per Employee	23,404,466.5x
Sector	Healthcare
Sic	2834
Symbol	tyo/4512
Website	https://www.wakamoto-pharm.co.jp

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.79%
FCF yield	1.59%
P/B ratio	1.03x
P/S ratio	1.32x
PE Ratio10 Y	52.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-5.3%
EBITDA Margin	5.39%
FCF margin	2.1%
Gross margin	53.86%
Gross Profit	JPY 5.1B
Gross Profit Growth	-1.85%
Gross Profit Growth Q	-12.03%
Gross Profit Growth3 Y	-6.56%
Gross Profit Growth5 Y	-5.66%
Net Income	JPY -222M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-1.36%
Profit Margin	-2.35%
Profit Per Employee	JPY -550,868
Profitable Years	4
ROA	-1.84
Roa5y	-0.32
ROCE	-3.35
ROE	-1.83
Roe5y	0.23
ROIC	-4.15
Roic5y	-1.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.22%
Cagr15y	3.18%
Cagr1y	9.43%
Cagr20y	-0.57%
Cagr3y	14.54%
Cagr5y	1.92%
Div CAGR10	0%
Div CAGR3	0%
Div CAGR5	0%
EPS Growth Quarters	2
EPS Growth Years	0
FCF Growth5 Y	-10.6%
OCF Growth	70.23%
OCF Growth3 Y	-10.61%
OCF Growth5 Y	-7.89%
Revenue Growth	-2.45x
Revenue Growth Q	-10.25x
Revenue Growth Quarters	3x
Revenue Growth Years	1x
Revenue Growth3 Y	-2.19x
Revenue Growth5 Y	-1.8x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	JPY 0.55
Assets	JPY 16.8B
Cash	JPY 1.9B
Current Assets	JPY 8.3B
Current Liabilities	JPY 1.9B
Debt	JPY 1.7B
Debt EBITDA	JPY 3.26
Debt Equity	JPY 0.14
Debt FCF	JPY 8.37
Equity	JPY 12.1B
Interest Coverage	-17.86
Liabilities	JPY 4.7B
Long Term Assets	JPY 8.5B
Long Term Liabilities	JPY 2.8B
Net Cash	JPY 212M
Net Cash By Market Cap	JPY 1.71
Net Cash Growth	35.9%
Net Debt EBITDA	JPY -0.42
Net Debt Equity	JPY -0.02
Net Debt FCF	JPY -1.07
Tangible Book Value	JPY 11.7B
Tangible Book Value Per Share	JPY 336
WACC	6.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.3
Inventory Turnover	1.92
Net Working Capital	JPY 4.8B
Quick ratio	2.81
Working Capital	JPY 6.4B
Working Capital Turnover	JPY 1.53

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.59%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	JPY 3
Dividend Years	4
Dividend Yield	0.84%
Ex Div Date	2026-03-30
Last Dividend	JPY 3
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	51.19%
1Y total return	9.43%
200-day SMA	308.6
3Y total return	50.28%
50-day SMA	344.3
50-day SMA vs 200-day SMA	50over200
5Y total return	9.98%
All Time High	909.1
All Time High Change	-60.73%
All Time High Date	1992-03-02
All Time Low	161
All Time Low Change	121.74%
All Time Low Date	2012-06-04
ATR	9.6
Beta	0.47
Beta1y	0.22
Beta2y	0.38
Ch YTD	24.83
High	364
High52	380
High52 Date	2026-03-26
High52ch	-6.05%
Low	353
Low52	271
Low52 Date	2025-11-19
Low52ch	31.73%
Ma50ch	3.69%
Price vs 200-day SMA	15.68%
RSI	55.56
RSI Monthly	67.19
RSI Weekly	62.52
Sharpe ratio	0.26x
Sortino ratio	0.58
Total Return	0.25%
Tr YTD	25.88
Tr15y	59.96%
Tr1m	4.39%
Tr1w	1.13%
Tr3m	9.76%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	JPY -500M
Operating margin	-5.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	21,433,145%
Net Borrowing	204,000,000
Shares Institutions	28.32%
Shares Out	34,792,045
Shares Qo Q	-0.02%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	JPY 198M
Average Volume	71,905x
Bv Per Share	347.8
CAPEX	JPY -391M
Ch10y	41.67
Ch15y	45.12
Ch1m	4.39
Ch1w	1.13
Ch1y	8.51
Ch20y	-24.52
Ch3m	8.84
Ch3y	45.71
Ch5y	5.31
Ch6m	26.15
Change	-1.38%
Change From Open	-1.92
Close	362
Days Gap	0.55
Depreciation Amortization	1,008,000,000
Dollar Volume	35,664,300
Earnings Date	2026-05-15
EBIT	JPY -500M
EBITDA	JPY 508M
EPS	JPY -6.38
F Score	5
FCF	JPY 198M
FCF Per Share	JPY 5.69
Financing CF	197,000,000
Fiscal Year End	March
Founded	1,929
Income Tax	JPY 94M
Investing CF	-505,000,000
Is Primary Listing	1
Last Earnings Date	2026-02-05
Last Report Date	2012-03-31
Last Split Date	1995-09-26
Last Split Type	Forward
Ma150	310.8
Ma150ch	14.87%
Ma20	349.7
Ma20ch	2.09%
Net CF	282,000,000
Next Earnings Date	2026-05-15
Open	364
P FCF Ratio	62.73
P OCF Ratio	21.09
Payment Date	2026-06-25
Position In Range	36.36
Ppne	5,002,000,000
Price Date	2026-05-08
Price EBITDA	JPY 24.45
Ptbv Ratio	1.06
Relative Volume	1.4x
Revenue	9,432,000,000x
Tax By Revenue	1x
Tr20y	-10.74%
Tr6m	27.21%
Volume	99,900
Z Score	2.46

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TYO/4512 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.8%

$3.00 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

0 consecutive years of growth

Total shareholder yield

+0.2%

Next ex-dividend date: 2026-03-30

Performance

TYO/4512 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TYO/4512?

Insider, institutional, and short-interest positioning.

Institutional ownership

+28.3%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

TYO/4512 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.6

Neutral momentum band

Price vs 200-day MA

+15.7%

50/200-day relationship not available

Beta (5Y)

0.47

Less volatile than the market

Sharpe ratio

0.26

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TYO/4512

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tyo/4512 stock rating?

tyo/4512 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tyo/4512 analysis?

The full report lives at /stocks/tyo/4512/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tyo/4512?

The latest report frames tyo/4512 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tyo/4512 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.